[Cryptococcal meningoencephalitis following immunosuppressive therapy].
Waldmann
K D
KD
Neurologisch-Psychiatrische Klinik, Vogtland-Klinikums, Plauen.
D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects*; D001921:Brain / Q000276:immunology / Q000473:pathology; D003455:Cryptococcus neoformans / Q000276:immunology; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D016919:Meningitis, Cryptococcal / Q000276:immunology* / Q000473:pathology; D008590:Meningoencephalitis / Q000276:immunology* / Q000473:pathology; D009894:Opportunistic Infections / Q000276:immunology* / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects*
D011239:Prednisolone; D001379:Azathioprine
Kryptokokken-Meningoenzephalitis nach immunsuppressiver Therapie.